Clinical Trials

Acetazolamide Efficacy in Ataxia in PMM2-CDG – Eva Morava-Kozicz, Mayo Clinic Objective 1 (Primary): To determine the efficacy of acetazolamide in improving ataxia in patients with PMM2-CDG. Objective 2 (Secondary): To evaluate for any adverse events related to longer term acetazolamide administration. Objective 3 (Secondary): To examine the effect of acetazolamide on PMM2 biomarkers including … Continue reading Clinical Trials